nodes	percent_of_prediction	percent_of_DWPC	metapath
Methacholine—Cough—Gemfibrozil—coronary artery disease	0.00328	0.00504	CcSEcCtD
Methacholine—Bronchospasm—Enalapril—coronary artery disease	0.00324	0.00497	CcSEcCtD
Methacholine—Loss of consciousness—Ticagrelor—coronary artery disease	0.00323	0.00496	CcSEcCtD
Methacholine—Cough—Ticagrelor—coronary artery disease	0.00321	0.00492	CcSEcCtD
Methacholine—Chest pain—Gemfibrozil—coronary artery disease	0.0032	0.00492	CcSEcCtD
Methacholine—Bronchospasm—Telmisartan—coronary artery disease	0.00319	0.0049	CcSEcCtD
Methacholine—L-Carnitine—MPO—coronary artery disease	0.00319	1	CrCbGaD
Methacholine—Lightheadedness—Lisinopril—coronary artery disease	0.00319	0.00489	CcSEcCtD
Methacholine—Headache—Tirofiban—coronary artery disease	0.00318	0.00488	CcSEcCtD
Methacholine—Chest pain—Ticagrelor—coronary artery disease	0.00313	0.0048	CcSEcCtD
Methacholine—Bronchospasm—Captopril—coronary artery disease	0.0031	0.00477	CcSEcCtD
Methacholine—Pruritus—Pitavastatin—coronary artery disease	0.00307	0.00471	CcSEcCtD
Methacholine—Shock—Gemfibrozil—coronary artery disease	0.00302	0.00464	CcSEcCtD
Methacholine—Nausea—Tirofiban—coronary artery disease	0.00302	0.00463	CcSEcCtD
Methacholine—Bronchospasm—Perindopril—coronary artery disease	0.00301	0.00463	CcSEcCtD
Methacholine—Shock—Ticagrelor—coronary artery disease	0.00295	0.00453	CcSEcCtD
Methacholine—Cough—Rosuvastatin—coronary artery disease	0.00289	0.00443	CcSEcCtD
Methacholine—Syncope—Acetylsalicylic acid—coronary artery disease	0.00288	0.00442	CcSEcCtD
Methacholine—Dizziness—Pitavastatin—coronary artery disease	0.00287	0.0044	CcSEcCtD
Methacholine—Loss of consciousness—Acetylsalicylic acid—coronary artery disease	0.00282	0.00434	CcSEcCtD
Methacholine—Hypotension—Ticagrelor—coronary artery disease	0.0028	0.0043	CcSEcCtD
Methacholine—Chest pain—Acetylsalicylic acid—coronary artery disease	0.00274	0.0042	CcSEcCtD
Methacholine—Headache—Pitavastatin—coronary artery disease	0.00272	0.00417	CcSEcCtD
Methacholine—Bradycardia—Trandolapril—coronary artery disease	0.00269	0.00413	CcSEcCtD
Methacholine—Bradycardia—Enalapril—coronary artery disease	0.00268	0.00412	CcSEcCtD
Methacholine—Cardiac arrest—Timolol—coronary artery disease	0.00265	0.00407	CcSEcCtD
Methacholine—Bradycardia—Telmisartan—coronary artery disease	0.00265	0.00406	CcSEcCtD
Methacholine—Shock—Acetylsalicylic acid—coronary artery disease	0.00258	0.00396	CcSEcCtD
Methacholine—Nausea—Pitavastatin—coronary artery disease	0.00257	0.00395	CcSEcCtD
Methacholine—Syncope—Clopidogrel—coronary artery disease	0.00253	0.00388	CcSEcCtD
Methacholine—Cough—Fenofibrate—coronary artery disease	0.00251	0.00385	CcSEcCtD
Methacholine—Bradycardia—Perindopril—coronary artery disease	0.0025	0.00383	CcSEcCtD
Methacholine—Loss of consciousness—Clopidogrel—coronary artery disease	0.00248	0.00381	CcSEcCtD
Methacholine—Cough—Clopidogrel—coronary artery disease	0.00246	0.00378	CcSEcCtD
Methacholine—Cardiac arrest—Lisinopril—coronary artery disease	0.00246	0.00377	CcSEcCtD
Methacholine—Chest pain—Fenofibrate—coronary artery disease	0.00244	0.00375	CcSEcCtD
Methacholine—Bronchospasm—Ramipril—coronary artery disease	0.00242	0.00372	CcSEcCtD
Methacholine—Syncope—Eplerenone—coronary artery disease	0.00241	0.0037	CcSEcCtD
Methacholine—Chest pain—Clopidogrel—coronary artery disease	0.0024	0.00369	CcSEcCtD
Methacholine—Cough—Ezetimibe—coronary artery disease	0.0024	0.00368	CcSEcCtD
Methacholine—Chest pain—Lovastatin—coronary artery disease	0.00239	0.00366	CcSEcCtD
Methacholine—Dizziness—Penbutolol—coronary artery disease	0.00238	0.00365	CcSEcCtD
Methacholine—Bronchospasm—Timolol—coronary artery disease	0.00237	0.00364	CcSEcCtD
Methacholine—Loss of consciousness—Eplerenone—coronary artery disease	0.00237	0.00363	CcSEcCtD
Methacholine—Cough—Eplerenone—coronary artery disease	0.00235	0.0036	CcSEcCtD
Methacholine—Chest pain—Ezetimibe—coronary artery disease	0.00234	0.00359	CcSEcCtD
Methacholine—Chest pain—Eplerenone—coronary artery disease	0.00229	0.00352	CcSEcCtD
Methacholine—Shock—Clopidogrel—coronary artery disease	0.00227	0.00348	CcSEcCtD
Methacholine—Headache—Penbutolol—coronary artery disease	0.00225	0.00346	CcSEcCtD
Methacholine—Chest pain—Simvastatin—coronary artery disease	0.00223	0.00343	CcSEcCtD
Methacholine—Syncope—Valsartan—coronary artery disease	0.00222	0.00341	CcSEcCtD
Methacholine—Syncope—Olmesartan—coronary artery disease	0.00221	0.00339	CcSEcCtD
Methacholine—Bronchospasm—Lisinopril—coronary artery disease	0.0022	0.00337	CcSEcCtD
Methacholine—Hypotension—Fenofibrate—coronary artery disease	0.00219	0.00336	CcSEcCtD
Methacholine—Loss of consciousness—Valsartan—coronary artery disease	0.00218	0.00334	CcSEcCtD
Methacholine—Pruritus—Gemfibrozil—coronary artery disease	0.00217	0.00333	CcSEcCtD
Methacholine—Loss of consciousness—Olmesartan—coronary artery disease	0.00217	0.00332	CcSEcCtD
Methacholine—Shock—Eplerenone—coronary artery disease	0.00216	0.00332	CcSEcCtD
Methacholine—Cough—Valsartan—coronary artery disease	0.00216	0.00332	CcSEcCtD
Methacholine—Syncope—Niacin—coronary artery disease	0.00216	0.00331	CcSEcCtD
Methacholine—Hypotension—Clopidogrel—coronary artery disease	0.00215	0.0033	CcSEcCtD
Methacholine—Cough—Olmesartan—coronary artery disease	0.00215	0.0033	CcSEcCtD
Methacholine—Nausea—Penbutolol—coronary artery disease	0.00214	0.00328	CcSEcCtD
Methacholine—Pruritus—Ticagrelor—coronary artery disease	0.00212	0.00326	CcSEcCtD
Methacholine—Loss of consciousness—Niacin—coronary artery disease	0.00212	0.00325	CcSEcCtD
Methacholine—Chest pain—Valsartan—coronary artery disease	0.00211	0.00324	CcSEcCtD
Methacholine—Cough—Niacin—coronary artery disease	0.0021	0.00322	CcSEcCtD
Methacholine—Chest pain—Olmesartan—coronary artery disease	0.0021	0.00322	CcSEcCtD
Methacholine—Cough—Pravastatin—coronary artery disease	0.00207	0.00318	CcSEcCtD
Methacholine—Syncope—Trandolapril—coronary artery disease	0.00206	0.00317	CcSEcCtD
Methacholine—Syncope—Enalapril—coronary artery disease	0.00206	0.00316	CcSEcCtD
Methacholine—Hypotension—Eplerenone—coronary artery disease	0.00205	0.00315	CcSEcCtD
Methacholine—Dizziness—Gemfibrozil—coronary artery disease	0.00203	0.00312	CcSEcCtD
Methacholine—Syncope—Telmisartan—coronary artery disease	0.00203	0.00311	CcSEcCtD
Methacholine—Loss of consciousness—Trandolapril—coronary artery disease	0.00202	0.00311	CcSEcCtD
Methacholine—Chest pain—Pravastatin—coronary artery disease	0.00202	0.0031	CcSEcCtD
Methacholine—Loss of consciousness—Enalapril—coronary artery disease	0.00202	0.00309	CcSEcCtD
Methacholine—Cough—Trandolapril—coronary artery disease	0.00201	0.00308	CcSEcCtD
Methacholine—Cough—Enalapril—coronary artery disease	0.002	0.00307	CcSEcCtD
Methacholine—Shock—Valsartan—coronary artery disease	0.00199	0.00305	CcSEcCtD
Methacholine—Loss of consciousness—Telmisartan—coronary artery disease	0.00199	0.00305	CcSEcCtD
Methacholine—Dizziness—Ticagrelor—coronary artery disease	0.00198	0.00304	CcSEcCtD
Methacholine—Shock—Olmesartan—coronary artery disease	0.00198	0.00304	CcSEcCtD
Methacholine—Cough—Telmisartan—coronary artery disease	0.00197	0.00303	CcSEcCtD
Methacholine—Syncope—Captopril—coronary artery disease	0.00197	0.00303	CcSEcCtD
Methacholine—Bradycardia—Timolol—coronary artery disease	0.00196	0.00301	CcSEcCtD
Methacholine—Chest pain—Trandolapril—coronary artery disease	0.00196	0.00301	CcSEcCtD
Methacholine—Vomiting—Gemfibrozil—coronary artery disease	0.00195	0.003	CcSEcCtD
Methacholine—Chest pain—Enalapril—coronary artery disease	0.00195	0.003	CcSEcCtD
Methacholine—Shock—Niacin—coronary artery disease	0.00193	0.00297	CcSEcCtD
Methacholine—Loss of consciousness—Captopril—coronary artery disease	0.00193	0.00297	CcSEcCtD
Methacholine—Chest pain—Telmisartan—coronary artery disease	0.00193	0.00296	CcSEcCtD
Methacholine—Headache—Gemfibrozil—coronary artery disease	0.00192	0.00295	CcSEcCtD
Methacholine—Cough—Captopril—coronary artery disease	0.00192	0.00295	CcSEcCtD
Methacholine—Syncope—Perindopril—coronary artery disease	0.00192	0.00294	CcSEcCtD
Methacholine—Pruritus—Rosuvastatin—coronary artery disease	0.00191	0.00293	CcSEcCtD
Methacholine—Vomiting—Ticagrelor—coronary artery disease	0.00191	0.00293	CcSEcCtD
Methacholine—Hypotension—Valsartan—coronary artery disease	0.00189	0.0029	CcSEcCtD
Methacholine—Hypotension—Olmesartan—coronary artery disease	0.00188	0.00288	CcSEcCtD
Methacholine—Headache—Ticagrelor—coronary artery disease	0.00188	0.00288	CcSEcCtD
Methacholine—Loss of consciousness—Perindopril—coronary artery disease	0.00188	0.00288	CcSEcCtD
Methacholine—Chest pain—Captopril—coronary artery disease	0.00187	0.00287	CcSEcCtD
Methacholine—Cough—Perindopril—coronary artery disease	0.00186	0.00286	CcSEcCtD
Methacholine—Pruritus—Acetylsalicylic acid—coronary artery disease	0.00186	0.00285	CcSEcCtD
Methacholine—Shock—Trandolapril—coronary artery disease	0.00185	0.00284	CcSEcCtD
Methacholine—Shock—Enalapril—coronary artery disease	0.00184	0.00283	CcSEcCtD
Methacholine—Hypotension—Niacin—coronary artery disease	0.00184	0.00282	CcSEcCtD
Methacholine—Nausea—Gemfibrozil—coronary artery disease	0.00182	0.0028	CcSEcCtD
Methacholine—Bradycardia—Lisinopril—coronary artery disease	0.00182	0.0028	CcSEcCtD
Methacholine—Chest pain—Perindopril—coronary artery disease	0.00182	0.00279	CcSEcCtD
Methacholine—Shock—Telmisartan—coronary artery disease	0.00182	0.00279	CcSEcCtD
Methacholine—Syncope—Losartan—coronary artery disease	0.0018	0.00276	CcSEcCtD
Methacholine—Dizziness—Rosuvastatin—coronary artery disease	0.00179	0.00274	CcSEcCtD
Methacholine—Nausea—Ticagrelor—coronary artery disease	0.00178	0.00273	CcSEcCtD
Methacholine—Shock—Captopril—coronary artery disease	0.00177	0.00271	CcSEcCtD
Methacholine—Loss of consciousness—Losartan—coronary artery disease	0.00176	0.0027	CcSEcCtD
Methacholine—Hypotension—Trandolapril—coronary artery disease	0.00176	0.00269	CcSEcCtD
Methacholine—Hypotension—Enalapril—coronary artery disease	0.00175	0.00268	CcSEcCtD
Methacholine—Cough—Losartan—coronary artery disease	0.00175	0.00268	CcSEcCtD
Methacholine—Dizziness—Acetylsalicylic acid—coronary artery disease	0.00173	0.00266	CcSEcCtD
Methacholine—Hypotension—Telmisartan—coronary artery disease	0.00172	0.00265	CcSEcCtD
Methacholine—Shock—Perindopril—coronary artery disease	0.00171	0.00263	CcSEcCtD
Methacholine—Chest pain—Losartan—coronary artery disease	0.00171	0.00262	CcSEcCtD
Methacholine—Headache—Rosuvastatin—coronary artery disease	0.00169	0.0026	CcSEcCtD
Methacholine—Hypotension—Captopril—coronary artery disease	0.00168	0.00257	CcSEcCtD
Methacholine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.00167	0.00256	CcSEcCtD
Methacholine—Shock—Furosemide—coronary artery disease	0.00167	0.00256	CcSEcCtD
Methacholine—Pruritus—Fenofibrate—coronary artery disease	0.00166	0.00254	CcSEcCtD
Methacholine—Pruritus—Clopidogrel—coronary artery disease	0.00163	0.0025	CcSEcCtD
Methacholine—Hypotension—Perindopril—coronary artery disease	0.00163	0.0025	CcSEcCtD
Methacholine—Pruritus—Lovastatin—coronary artery disease	0.00162	0.00248	CcSEcCtD
Methacholine—Shock—Losartan—coronary artery disease	0.00161	0.00247	CcSEcCtD
Methacholine—Nausea—Rosuvastatin—coronary artery disease	0.0016	0.00246	CcSEcCtD
Methacholine—Pruritus—Ezetimibe—coronary artery disease	0.00159	0.00244	CcSEcCtD
Methacholine—Hypotension—Furosemide—coronary artery disease	0.00158	0.00243	CcSEcCtD
Methacholine—Nausea—Acetylsalicylic acid—coronary artery disease	0.00156	0.00239	CcSEcCtD
Methacholine—Pruritus—Eplerenone—coronary artery disease	0.00155	0.00239	CcSEcCtD
Methacholine—Dizziness—Fenofibrate—coronary artery disease	0.00155	0.00238	CcSEcCtD
Methacholine—Syncope—Ramipril—coronary artery disease	0.00154	0.00236	CcSEcCtD
Methacholine—Hypotension—Losartan—coronary artery disease	0.00153	0.00234	CcSEcCtD
Methacholine—Dizziness—Clopidogrel—coronary artery disease	0.00152	0.00234	CcSEcCtD
Methacholine—Pruritus—Simvastatin—coronary artery disease	0.00151	0.00232	CcSEcCtD
Methacholine—Dizziness—Lovastatin—coronary artery disease	0.00151	0.00232	CcSEcCtD
Methacholine—Loss of consciousness—Ramipril—coronary artery disease	0.00151	0.00232	CcSEcCtD
Methacholine—Syncope—Timolol—coronary artery disease	0.00151	0.00231	CcSEcCtD
Methacholine—Cough—Ramipril—coronary artery disease	0.0015	0.0023	CcSEcCtD
Methacholine—Vomiting—Fenofibrate—coronary artery disease	0.00149	0.00229	CcSEcCtD
Methacholine—Dizziness—Ezetimibe—coronary artery disease	0.00148	0.00228	CcSEcCtD
Methacholine—Loss of consciousness—Timolol—coronary artery disease	0.00148	0.00226	CcSEcCtD
Methacholine—Headache—Fenofibrate—coronary artery disease	0.00147	0.00225	CcSEcCtD
Methacholine—Cough—Timolol—coronary artery disease	0.00147	0.00225	CcSEcCtD
Methacholine—Vomiting—Clopidogrel—coronary artery disease	0.00146	0.00225	CcSEcCtD
Methacholine—Chest pain—Ramipril—coronary artery disease	0.00146	0.00224	CcSEcCtD
Methacholine—Vomiting—Lovastatin—coronary artery disease	0.00145	0.00223	CcSEcCtD
Methacholine—Dizziness—Eplerenone—coronary artery disease	0.00145	0.00223	CcSEcCtD
Methacholine—Headache—Clopidogrel—coronary artery disease	0.00144	0.00221	CcSEcCtD
Methacholine—Headache—Lovastatin—coronary artery disease	0.00143	0.0022	CcSEcCtD
Methacholine—Pruritus—Valsartan—coronary artery disease	0.00143	0.00219	CcSEcCtD
Methacholine—Chest pain—Timolol—coronary artery disease	0.00143	0.00219	CcSEcCtD
Methacholine—Vomiting—Ezetimibe—coronary artery disease	0.00143	0.00219	CcSEcCtD
Methacholine—Pruritus—Olmesartan—coronary artery disease	0.00142	0.00218	CcSEcCtD
Methacholine—Dizziness—Simvastatin—coronary artery disease	0.00142	0.00217	CcSEcCtD
Methacholine—Headache—Ezetimibe—coronary artery disease	0.00141	0.00216	CcSEcCtD
Methacholine—Syncope—Lisinopril—coronary artery disease	0.0014	0.00214	CcSEcCtD
Methacholine—Vomiting—Eplerenone—coronary artery disease	0.0014	0.00214	CcSEcCtD
Methacholine—Nausea—Fenofibrate—coronary artery disease	0.00139	0.00214	CcSEcCtD
Methacholine—Pruritus—Niacin—coronary artery disease	0.00139	0.00213	CcSEcCtD
Methacholine—Shock—Ramipril—coronary artery disease	0.00138	0.00212	CcSEcCtD
Methacholine—Headache—Eplerenone—coronary artery disease	0.00138	0.00211	CcSEcCtD
Methacholine—Pruritus—Pravastatin—coronary artery disease	0.00137	0.0021	CcSEcCtD
Methacholine—Loss of consciousness—Lisinopril—coronary artery disease	0.00137	0.0021	CcSEcCtD
Methacholine—Nausea—Clopidogrel—coronary artery disease	0.00137	0.0021	CcSEcCtD
Methacholine—Vomiting—Simvastatin—coronary artery disease	0.00136	0.00209	CcSEcCtD
Methacholine—Cough—Lisinopril—coronary artery disease	0.00136	0.00209	CcSEcCtD
Methacholine—Nausea—Lovastatin—coronary artery disease	0.00136	0.00209	CcSEcCtD
Methacholine—Shock—Timolol—coronary artery disease	0.00135	0.00207	CcSEcCtD
Methacholine—Headache—Simvastatin—coronary artery disease	0.00134	0.00206	CcSEcCtD
Methacholine—Dizziness—Valsartan—coronary artery disease	0.00134	0.00205	CcSEcCtD
Methacholine—Nausea—Ezetimibe—coronary artery disease	0.00133	0.00205	CcSEcCtD
Methacholine—Dizziness—Olmesartan—coronary artery disease	0.00133	0.00204	CcSEcCtD
Methacholine—Pruritus—Trandolapril—coronary artery disease	0.00133	0.00204	CcSEcCtD
Methacholine—Chest pain—Lisinopril—coronary artery disease	0.00133	0.00204	CcSEcCtD
Methacholine—Pruritus—Enalapril—coronary artery disease	0.00132	0.00203	CcSEcCtD
Methacholine—Hypotension—Ramipril—coronary artery disease	0.00131	0.00201	CcSEcCtD
Methacholine—Pruritus—Telmisartan—coronary artery disease	0.00131	0.002	CcSEcCtD
Methacholine—Nausea—Eplerenone—coronary artery disease	0.0013	0.002	CcSEcCtD
Methacholine—Dizziness—Niacin—coronary artery disease	0.0013	0.00199	CcSEcCtD
Methacholine—Vomiting—Valsartan—coronary artery disease	0.00129	0.00197	CcSEcCtD
Methacholine—Hypotension—Timolol—coronary artery disease	0.00128	0.00197	CcSEcCtD
Methacholine—Dizziness—Pravastatin—coronary artery disease	0.00128	0.00196	CcSEcCtD
Methacholine—Vomiting—Olmesartan—coronary artery disease	0.00128	0.00196	CcSEcCtD
Methacholine—Nausea—Simvastatin—coronary artery disease	0.00127	0.00195	CcSEcCtD
Methacholine—Pruritus—Captopril—coronary artery disease	0.00127	0.00195	CcSEcCtD
Methacholine—Headache—Valsartan—coronary artery disease	0.00127	0.00194	CcSEcCtD
Methacholine—Headache—Olmesartan—coronary artery disease	0.00126	0.00193	CcSEcCtD
Methacholine—Shock—Lisinopril—coronary artery disease	0.00125	0.00192	CcSEcCtD
Methacholine—Vomiting—Niacin—coronary artery disease	0.00125	0.00192	CcSEcCtD
Methacholine—Dizziness—Trandolapril—coronary artery disease	0.00124	0.00191	CcSEcCtD
Methacholine—Dizziness—Enalapril—coronary artery disease	0.00124	0.0019	CcSEcCtD
Methacholine—Pruritus—Perindopril—coronary artery disease	0.00123	0.00189	CcSEcCtD
Methacholine—Headache—Niacin—coronary artery disease	0.00123	0.00189	CcSEcCtD
Methacholine—Vomiting—Pravastatin—coronary artery disease	0.00123	0.00189	CcSEcCtD
Methacholine—Dizziness—Telmisartan—coronary artery disease	0.00122	0.00187	CcSEcCtD
Methacholine—Headache—Pravastatin—coronary artery disease	0.00121	0.00186	CcSEcCtD
Methacholine—Nausea—Valsartan—coronary artery disease	0.0012	0.00184	CcSEcCtD
Methacholine—Pruritus—Furosemide—coronary artery disease	0.0012	0.00184	CcSEcCtD
Methacholine—Nausea—Olmesartan—coronary artery disease	0.00119	0.00183	CcSEcCtD
Methacholine—Vomiting—Trandolapril—coronary artery disease	0.00119	0.00183	CcSEcCtD
Methacholine—Vomiting—Enalapril—coronary artery disease	0.00119	0.00183	CcSEcCtD
Methacholine—Hypotension—Lisinopril—coronary artery disease	0.00119	0.00182	CcSEcCtD
Methacholine—Dizziness—Captopril—coronary artery disease	0.00119	0.00182	CcSEcCtD
Methacholine—Headache—Trandolapril—coronary artery disease	0.00118	0.00181	CcSEcCtD
Methacholine—Vomiting—Telmisartan—coronary artery disease	0.00117	0.0018	CcSEcCtD
Methacholine—Headache—Enalapril—coronary artery disease	0.00117	0.0018	CcSEcCtD
Methacholine—Nausea—Niacin—coronary artery disease	0.00117	0.00179	CcSEcCtD
Methacholine—Pruritus—Losartan—coronary artery disease	0.00116	0.00178	CcSEcCtD
Methacholine—Headache—Telmisartan—coronary artery disease	0.00116	0.00177	CcSEcCtD
Methacholine—Dizziness—Perindopril—coronary artery disease	0.00115	0.00177	CcSEcCtD
Methacholine—Nausea—Pravastatin—coronary artery disease	0.00115	0.00176	CcSEcCtD
Methacholine—Vomiting—Captopril—coronary artery disease	0.00114	0.00175	CcSEcCtD
Methacholine—Headache—Captopril—coronary artery disease	0.00112	0.00173	CcSEcCtD
Methacholine—Dizziness—Furosemide—coronary artery disease	0.00112	0.00172	CcSEcCtD
Methacholine—Nausea—Trandolapril—coronary artery disease	0.00112	0.00171	CcSEcCtD
Methacholine—Nausea—Enalapril—coronary artery disease	0.00111	0.00171	CcSEcCtD
Methacholine—Vomiting—Perindopril—coronary artery disease	0.00111	0.0017	CcSEcCtD
Methacholine—Nausea—Telmisartan—coronary artery disease	0.0011	0.00168	CcSEcCtD
Methacholine—Headache—Perindopril—coronary artery disease	0.00109	0.00168	CcSEcCtD
Methacholine—Dizziness—Losartan—coronary artery disease	0.00108	0.00166	CcSEcCtD
Methacholine—Vomiting—Furosemide—coronary artery disease	0.00108	0.00165	CcSEcCtD
Methacholine—Nausea—Captopril—coronary artery disease	0.00107	0.00164	CcSEcCtD
Methacholine—Headache—Furosemide—coronary artery disease	0.00106	0.00163	CcSEcCtD
Methacholine—Vomiting—Losartan—coronary artery disease	0.00104	0.0016	CcSEcCtD
Methacholine—Nausea—Perindopril—coronary artery disease	0.00104	0.00159	CcSEcCtD
Methacholine—Headache—Losartan—coronary artery disease	0.00102	0.00157	CcSEcCtD
Methacholine—Nausea—Furosemide—coronary artery disease	0.00101	0.00154	CcSEcCtD
Methacholine—Pruritus—Ramipril—coronary artery disease	0.000992	0.00152	CcSEcCtD
Methacholine—Nausea—Losartan—coronary artery disease	0.000971	0.00149	CcSEcCtD
Methacholine—Pruritus—Timolol—coronary artery disease	0.000969	0.00149	CcSEcCtD
Methacholine—Dizziness—Ramipril—coronary artery disease	0.000927	0.00142	CcSEcCtD
Methacholine—Dizziness—Timolol—coronary artery disease	0.000906	0.00139	CcSEcCtD
Methacholine—Pruritus—Lisinopril—coronary artery disease	0.000899	0.00138	CcSEcCtD
Methacholine—Vomiting—Ramipril—coronary artery disease	0.000891	0.00137	CcSEcCtD
Methacholine—Headache—Ramipril—coronary artery disease	0.000878	0.00135	CcSEcCtD
Methacholine—Vomiting—Timolol—coronary artery disease	0.000871	0.00134	CcSEcCtD
Methacholine—Headache—Timolol—coronary artery disease	0.000858	0.00132	CcSEcCtD
Methacholine—Dizziness—Lisinopril—coronary artery disease	0.000841	0.00129	CcSEcCtD
Methacholine—Nausea—Ramipril—coronary artery disease	0.000833	0.00128	CcSEcCtD
Methacholine—Nausea—Timolol—coronary artery disease	0.000814	0.00125	CcSEcCtD
Methacholine—Vomiting—Lisinopril—coronary artery disease	0.000808	0.00124	CcSEcCtD
Methacholine—Headache—Lisinopril—coronary artery disease	0.000796	0.00122	CcSEcCtD
Methacholine—Nausea—Lisinopril—coronary artery disease	0.000755	0.00116	CcSEcCtD
Methacholine—CHRM2—Signaling by GPCR—CSF2—coronary artery disease	9.31e-05	0.00027	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCR3—coronary artery disease	9.27e-05	0.000269	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—HTR2A—coronary artery disease	9.27e-05	0.000268	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—C3—coronary artery disease	9.25e-05	0.000268	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCR3—coronary artery disease	9.18e-05	0.000266	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—HTR2A—coronary artery disease	9.18e-05	0.000266	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—C3—coronary artery disease	9.16e-05	0.000265	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CRK—coronary artery disease	9.15e-05	0.000265	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CRK—coronary artery disease	9.06e-05	0.000262	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SH2B3—coronary artery disease	9.03e-05	0.000262	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—VWF—coronary artery disease	9.03e-05	0.000262	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ATP2A2—coronary artery disease	9.03e-05	0.000262	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOC3—coronary artery disease	8.98e-05	0.00026	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SH2B3—coronary artery disease	8.95e-05	0.000259	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ATP2A2—coronary artery disease	8.95e-05	0.000259	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—VWF—coronary artery disease	8.95e-05	0.000259	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LDLR—coronary artery disease	8.92e-05	0.000258	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOC3—coronary artery disease	8.89e-05	0.000258	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LDLR—coronary artery disease	8.84e-05	0.000256	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AGT—coronary artery disease	8.79e-05	0.000255	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PPP2CA—coronary artery disease	8.76e-05	0.000254	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CXCL2—coronary artery disease	8.72e-05	0.000252	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCL3—coronary artery disease	8.72e-05	0.000252	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AGT—coronary artery disease	8.71e-05	0.000252	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PPP2CA—coronary artery disease	8.67e-05	0.000251	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PLCB1—coronary artery disease	8.67e-05	0.000251	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCL3—coronary artery disease	8.63e-05	0.00025	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CXCL2—coronary artery disease	8.63e-05	0.00025	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—F2R—coronary artery disease	8.62e-05	0.00025	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SDC1—coronary artery disease	8.62e-05	0.00025	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PRKCD—coronary artery disease	8.6e-05	0.000249	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SDC1—coronary artery disease	8.53e-05	0.000247	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—F2R—coronary artery disease	8.53e-05	0.000247	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PRKCD—coronary artery disease	8.52e-05	0.000247	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGB—coronary artery disease	8.43e-05	0.000244	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—HTR2A—coronary artery disease	8.41e-05	0.000244	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—C3—coronary artery disease	8.4e-05	0.000243	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ABCA1—coronary artery disease	8.4e-05	0.000243	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGB—coronary artery disease	8.35e-05	0.000242	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EDNRB—coronary artery disease	8.35e-05	0.000242	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—HTR2A—coronary artery disease	8.33e-05	0.000241	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—C3—coronary artery disease	8.32e-05	0.000241	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EDNRB—coronary artery disease	8.27e-05	0.000239	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—THBS1—coronary artery disease	8.22e-05	0.000238	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—THBS1—coronary artery disease	8.14e-05	0.000236	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PSMA6—coronary artery disease	8.14e-05	0.000236	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PSMB5—coronary artery disease	8.14e-05	0.000236	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GOT1—coronary artery disease	8.14e-05	0.000236	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GGT1—coronary artery disease	8.14e-05	0.000236	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—F2—coronary artery disease	8.12e-05	0.000235	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PSMA6—coronary artery disease	8.06e-05	0.000234	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PSMB5—coronary artery disease	8.06e-05	0.000234	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—F2—coronary artery disease	8.04e-05	0.000233	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AGT—coronary artery disease	7.98e-05	0.000231	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AGT—coronary artery disease	7.91e-05	0.000229	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EDNRA—coronary artery disease	7.88e-05	0.000228	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CYBA—coronary artery disease	7.85e-05	0.000227	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADRB1—coronary artery disease	7.85e-05	0.000227	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—DUSP6—coronary artery disease	7.81e-05	0.000226	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EDNRA—coronary artery disease	7.81e-05	0.000226	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADRB1—coronary artery disease	7.77e-05	0.000225	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CYBA—coronary artery disease	7.77e-05	0.000225	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—DUSP6—coronary artery disease	7.74e-05	0.000224	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PLAT—coronary artery disease	7.68e-05	0.000222	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PLAT—coronary artery disease	7.61e-05	0.00022	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CXCL12—coronary artery disease	7.41e-05	0.000215	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—BDKRB2—coronary artery disease	7.41e-05	0.000215	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—POMC—coronary artery disease	7.4e-05	0.000214	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—F2—coronary artery disease	7.38e-05	0.000214	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL6ST—coronary artery disease	7.35e-05	0.000213	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CXCL12—coronary artery disease	7.34e-05	0.000213	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—BDKRB2—coronary artery disease	7.34e-05	0.000213	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—POMC—coronary artery disease	7.33e-05	0.000212	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTP1—coronary artery disease	7.31e-05	0.000212	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—F2—coronary artery disease	7.31e-05	0.000212	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL6ST—coronary artery disease	7.28e-05	0.000211	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—JUNB—coronary artery disease	7.27e-05	0.000211	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PLCB1—coronary artery disease	7.25e-05	0.00021	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PPARGC1A—coronary artery disease	7.24e-05	0.00021	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—HMOX1—coronary artery disease	7.21e-05	0.000209	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—JUNB—coronary artery disease	7.2e-05	0.000209	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PLCB1—coronary artery disease	7.18e-05	0.000208	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CAT—coronary artery disease	7.11e-05	0.000206	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HTR7—coronary artery disease	7.1e-05	0.000206	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HTR7—coronary artery disease	7.03e-05	0.000204	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOB—coronary artery disease	6.91e-05	0.0002	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ITGAV—coronary artery disease	6.76e-05	0.000196	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KNG1—coronary artery disease	6.74e-05	0.000195	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—POMC—coronary artery disease	6.72e-05	0.000195	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CREB1—coronary artery disease	6.72e-05	0.000195	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTM1—coronary artery disease	6.72e-05	0.000195	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AGTR1—coronary artery disease	6.7e-05	0.000194	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ITGAV—coronary artery disease	6.7e-05	0.000194	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KNG1—coronary artery disease	6.68e-05	0.000193	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—POMC—coronary artery disease	6.66e-05	0.000193	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CREB1—coronary artery disease	6.66e-05	0.000193	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AGTR1—coronary artery disease	6.64e-05	0.000192	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—LPL—coronary artery disease	6.59e-05	0.000191	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CCL2—coronary artery disease	6.58e-05	0.00019	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL6R—coronary artery disease	6.56e-05	0.00019	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CXCL10—coronary artery disease	6.55e-05	0.00019	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PLG—coronary artery disease	6.53e-05	0.000189	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CCL2—coronary artery disease	6.51e-05	0.000189	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL6R—coronary artery disease	6.49e-05	0.000188	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CXCL10—coronary artery disease	6.49e-05	0.000188	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PLG—coronary artery disease	6.47e-05	0.000187	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GPX1—coronary artery disease	6.43e-05	0.000186	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADRB2—coronary artery disease	6.36e-05	0.000184	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADRB2—coronary artery disease	6.3e-05	0.000182	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRKCE—coronary artery disease	6.28e-05	0.000182	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—JAK2—coronary artery disease	6.27e-05	0.000182	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CD36—coronary artery disease	6.26e-05	0.000181	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SOCS1—coronary artery disease	6.26e-05	0.000181	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—S100B—coronary artery disease	6.25e-05	0.000181	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRKCE—coronary artery disease	6.22e-05	0.00018	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—JAK2—coronary artery disease	6.21e-05	0.00018	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SOCS1—coronary artery disease	6.2e-05	0.00018	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PPP2CA—coronary artery disease	6.19e-05	0.000179	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—S100B—coronary artery disease	6.19e-05	0.000179	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SOCS3—coronary artery disease	6.19e-05	0.000179	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SOCS3—coronary artery disease	6.13e-05	0.000177	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KITLG—coronary artery disease	6.11e-05	0.000177	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TGFBR2—coronary artery disease	6.11e-05	0.000177	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TGFBR2—coronary artery disease	6.05e-05	0.000175	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KITLG—coronary artery disease	6.05e-05	0.000175	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MMP3—coronary artery disease	5.97e-05	0.000173	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—STAT5A—coronary artery disease	5.97e-05	0.000173	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—MTHFR—coronary artery disease	5.94e-05	0.000172	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MMP3—coronary artery disease	5.92e-05	0.000171	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—STAT5A—coronary artery disease	5.92e-05	0.000171	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOB—coronary artery disease	5.77e-05	0.000167	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—CXCL8—coronary artery disease	5.72e-05	0.000166	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOB—coronary artery disease	5.72e-05	0.000166	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—JAK2—coronary artery disease	5.7e-05	0.000165	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EDN1—coronary artery disease	5.68e-05	0.000165	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	5.67e-05	0.000164	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	5.64e-05	0.000163	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AGT—coronary artery disease	5.64e-05	0.000163	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCL5—coronary artery disease	5.64e-05	0.000163	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EDN1—coronary artery disease	5.63e-05	0.000163	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCL5—coronary artery disease	5.58e-05	0.000162	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CSF2—coronary artery disease	5.55e-05	0.000161	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGF1—coronary artery disease	5.55e-05	0.000161	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOE—coronary artery disease	5.53e-05	0.00016	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LPL—coronary artery disease	5.51e-05	0.00016	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGF1—coronary artery disease	5.5e-05	0.000159	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CSF2—coronary artery disease	5.5e-05	0.000159	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	5.46e-05	0.000158	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	5.46e-05	0.000158	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOA1—coronary artery disease	5.46e-05	0.000158	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LPL—coronary artery disease	5.46e-05	0.000158	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	5.41e-05	0.000157	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	5.41e-05	0.000157	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	5.32e-05	0.000154	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	5.27e-05	0.000153	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	5.2e-05	0.000151	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	5.17e-05	0.00015	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	5.15e-05	0.000149	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	5.12e-05	0.000148	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	5.08e-05	0.000147	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	5.03e-05	0.000146	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	4.97e-05	0.000144	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—C3—coronary artery disease	4.96e-05	0.000144	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	4.92e-05	0.000143	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—C3—coronary artery disease	4.92e-05	0.000142	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PPARG—coronary artery disease	4.81e-05	0.000139	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—POMC—coronary artery disease	4.75e-05	0.000138	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	4.73e-05	0.000137	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AGT—coronary artery disease	4.72e-05	0.000137	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	4.69e-05	0.000136	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AGT—coronary artery disease	4.67e-05	0.000135	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LEP—coronary artery disease	4.62e-05	0.000134	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOE—coronary artery disease	4.62e-05	0.000134	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LEP—coronary artery disease	4.58e-05	0.000133	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOE—coronary artery disease	4.58e-05	0.000133	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOA1—coronary artery disease	4.57e-05	0.000132	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KDR—coronary artery disease	4.53e-05	0.000131	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOA1—coronary artery disease	4.52e-05	0.000131	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	4.5e-05	0.00013	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KDR—coronary artery disease	4.48e-05	0.00013	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	4.45e-05	0.000129	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ESR1—coronary artery disease	4.41e-05	0.000128	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ESR1—coronary artery disease	4.37e-05	0.000127	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—F2—coronary artery disease	4.36e-05	0.000126	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FN1—coronary artery disease	4.36e-05	0.000126	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	4.34e-05	0.000126	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ALB—coronary artery disease	4.33e-05	0.000125	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—F2—coronary artery disease	4.32e-05	0.000125	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FN1—coronary artery disease	4.32e-05	0.000125	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	4.31e-05	0.000125	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	4.3e-05	0.000124	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	4.26e-05	0.000124	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KIT—coronary artery disease	4.17e-05	0.000121	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NOS3—coronary artery disease	4.14e-05	0.00012	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KIT—coronary artery disease	4.13e-05	0.00012	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	4e-05	0.000116	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CREB1—coronary artery disease	3.97e-05	0.000115	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—POMC—coronary artery disease	3.97e-05	0.000115	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	3.96e-05	0.000115	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—POMC—coronary artery disease	3.93e-05	0.000114	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CREB1—coronary artery disease	3.93e-05	0.000114	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCL2—coronary artery disease	3.88e-05	0.000113	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL6R—coronary artery disease	3.87e-05	0.000112	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCL2—coronary artery disease	3.85e-05	0.000111	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL6R—coronary artery disease	3.83e-05	0.000111	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF1—coronary artery disease	3.82e-05	0.000111	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	3.8e-05	0.00011	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PTGS2—coronary artery disease	3.79e-05	0.00011	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF1—coronary artery disease	3.78e-05	0.00011	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	3.76e-05	0.000109	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	3.63e-05	0.000105	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	3.63e-05	0.000105	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	3.6e-05	0.000104	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	3.59e-05	0.000104	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGF2—coronary artery disease	3.51e-05	0.000102	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	3.48e-05	0.000101	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOS3—coronary artery disease	3.46e-05	0.0001	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	3.43e-05	9.93e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—JAK2—coronary artery disease	3.36e-05	9.75e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	3.33e-05	9.65e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	3.3e-05	9.55e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	3.27e-05	9.46e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	3.07e-05	8.89e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	3.04e-05	8.81e-05	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	2.97e-05	8.59e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CASP3—coronary artery disease	2.94e-05	8.51e-05	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	2.94e-05	8.51e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL6—coronary artery disease	2.92e-05	8.46e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	2.91e-05	8.43e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	2.89e-05	8.38e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCND1—coronary artery disease	2.86e-05	8.29e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	2.83e-05	8.21e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MMP9—coronary artery disease	2.78e-05	8.05e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	2.75e-05	7.97e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	2.69e-05	7.8e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	2.67e-05	7.73e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	2.49e-05	7.22e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	2.47e-05	7.15e-05	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CA—coronary artery disease	2.33e-05	6.75e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	2.29e-05	6.63e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	2.27e-05	6.57e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	2.25e-05	6.5e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	2.22e-05	6.44e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	1.95e-05	5.64e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	1.93e-05	5.59e-05	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AKT1—coronary artery disease	1.9e-05	5.51e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL6—coronary artery disease	1.73e-05	5e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL6—coronary artery disease	1.71e-05	4.95e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKT1—coronary artery disease	1.59e-05	4.61e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	1.58e-05	4.56e-05	CbGpPWpGaD
